Clinical Trial Update: Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers [Phase 2]

View source ↗

Summary

This update describes a Phase 2 study of the combination of nivolumab and ipilimumab in children and young adults with INI1-negative cancers, including malignan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Teratoid Rhabdoid Tumor
• Chordoma
• Epithelioid Sarcoma
• Malignant Rhabdoid Tumor
• Other Ini1-negative Tumors
• Other Smarca4-deficient Malignant Tumors
• Rhabdoid Tumor of the Kidney

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Malignant Rhabdoid Tumor, Rhabdoid Tumor of the Kidney | Phase 2 | Status: ACTIVE_NOT_RECRUITING